CLASS II ONGOING Device recall · Reported 5 Jun 2024 · FDA Enforcement Report

RefleXion X1 Radiotherapy System recalled by Reflexion Medical

Reflexion Medical is recalling RefleXion X1 Radiotherapy System, distributed in California, Connecticut, New Jersey, Oregon, Pennsylvania, Texas. The recall was initiated on 16 Apr 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel Number: RXM1000 UDI Codes that includes system serial numbers: (01)00860003983812(11)230504(21)X11001 (01)00860003983812(11)230518(21)X11002 (01)00860003983812(11)230505(21)X11003 (01)00860003983812(11)230530(21)X11004 (01)00860003983812(11)230811(21)X11006 (01)00860003983812(11)230410(21)X11007 (01)00860003983812(11)230803(21)X11008
Quantity recalled7 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1933-2024
FDA event ID
94533
Recalling firm
Reflexion Medical, Hayward, CA
Classification
Class II
Status
Ongoing
Recall initiated
16 Apr 2024
FDA classified
30 May 2024
Reported
5 Jun 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

16 Apr 2024Recall initiated by company
30 May 2024Classified by FDA+44 days
5 Jun 2024Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

RefleXion X1 Radiotherapy System Model RXM1000 Software version 2.1.19-3 Radiation therapy system is a device that combines the functionality of an emission computed tomography detection system and a linear accelerator.

Where it was distributed

U.S.: CA, CT, NJ, OR, PA and TX No O.U.S.

CaliforniaConnecticutNew JerseyOregonPennsylvaniaTexas

Questions about this recall

Why was it recalled?

A potential dose error exists for patients treated with an out of session SCINTIX partial fraction.

Which lots are affected?

Model Number: RXM1000 UDI Codes that includes system serial numbers: (01)00860003983812(11)230504(21)X11001 (01)00860003983812(11)230518(21)X11002 (01)00860003983812(11)230505(21)X11003 (01)00860003983812(11)230530(21)X11004 (01)00860003983812(11)230811(21)X11006 (01)00860003983812(11)230410(21)X11007 (01)00860003983812(11)230803(21)X11008

Where was it sold?

U.S.: CA, CT, NJ, OR, PA and TX No O.U.S.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Reflexion Medical

All 4

Other Medical Software recalls

All 930